Incremental Predictive Value of ECG Burden Added to Clinical Risk for Appropriate ICD Therapy Selection: Model Development and Internal Validation
,
Abstract
Background: Risk stratification for selecting appropriate implantable cardioverter-defibrillator (ICD) therapy remains imperfect, and pragmatic electrocardiogram (ECG)-derived markers may provide incremental information beyond routine clinical variables.
Objective: We sought to evaluate whether a prespecified 6-component ECG burden score improves the prediction of appropriate ICD therapy selection beyond a minimal clinical model.
Methods: Retrospective prediction study using deidentified data from a parent ICD cohort at King Abdulaziz Medical City, Riyadh (n=236; 35 events; mean [SD] follow-up, 7.3 [2.3] years), analyzed under King Abdulaziz Hospital/KAIMRC governance (Protocol No. NRA 26/004/1). Minimal clinical predictors (age, sex, left ventricular ejection fraction, cardiomyopathy type, and ICD indication) were modeled with ridge logistic regression (clinical only) and with the addition of ECG burden (combined). Internal validation used 5-fold cross-validation with out-of-fold predictions.
Results: In complete-case modeling (n=231), out-of-fold discrimination was 0.502 for clinical only and 0.452 for combined (ΔAUC, −0.050; 95% CI, −0.097 to −0.008). In the imputed sensitivity analysis (n=236), discrimination was 0.514 vs 0.485 (ΔAUC, −0.028; 95% CI, −0.066 to 0.008). Decision curve analysis showed minimal separation between the models.
Conclusion: In internal validation, adding the ECG burden score did not improve discrimination beyond minimal clinical predictors and provided only minimal incremental clinical utility in predicting appropriate ICD therapy selection.
2. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-83.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-37.
5. Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models. BMJ. 2024;385:e078378.
6. Moons KGM, Damen JAA, Kaul T, Hooft L, Andaur Navarro C, Dhiman P, et al. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models. BMJ. 2025;388:e082505.
7. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-74.
8. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774-81.
9. Brier GW. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78(1):1-3.
10. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated ROC curves: a nonparametric approach. Biometrics. 1988;44(3):837-45.
| Files | ||
| Issue | Vol 21 No 3 (2026) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/rhythm.v21i3.22562 | |
| Keywords | ||
| Implantable Cardioverter-Defibrillator Electrocardiogram Risk Prediction Logistic Regression Cross-Validation Decision Curve Analysis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
